Results 191 to 200 of about 39,794 (275)

Combination Between Biomarkers and Echocardiographic Data for Prediction of Left Ventricular Reverse Remodelling in Cardiac Resynchronization Therapy. [PDF]

J Clin Med
Beltrami M, Galluzzo A, Bonacchi G, Checchi L, Ricciardi G, Perrotta L, Garofalo M, Paoletti Perini A, Mattesini A, Pieragnoli P, Palazzuoli A.   +10 more
europepmc   +1 more source

Mitral valve transcatheter edge‐to‐edge repair in the elderly—A safe and effective therapy

ESC Heart Failure, Volume 12, Issue 3, Page 1663-1675, June 2025.
Mitral valve transcatheter edge‐to‐edge repair in elderly patients is safe and offers comparable mitral valve regurgitation reduction and symptom relief to younger patients. At 3 years, increased all‐cause mortality is observed in elderly patients with advanced heart failure and elevated EuroSCORE II.
Dominik Felbel, Michael Paukovitsch, Matthias Gröger, Sinisa Markovic, Leonhard Schneider, Wolfgang Rottbauer, Mirjam Keßler   +6 more
wiley   +1 more source

Real‐world comparative effectiveness of sacubitril/valsartan versus RAS inhibition alone in patients with de novo heart failure

ESC Heart Failure, Volume 12, Issue 3, Page 1682-1692, June 2025.
Abstract Aims Large‐scale, real‐world data on early initiation of sacubitril/valsartan in patients newly diagnosed (de novo) with HF with reduced ejection fraction (HFrEF) are limited. We examined the effectiveness of sacubitril/valsartan versus angiotensin‐converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB) on all‐cause and cause ...
Ankeet S. Bhatt, Muthiah Vaduganathan, Barada P. Jena, Sylwia Suminska, Carlos Eid, Heike Schwende, Michele Senni   +6 more
wiley   +1 more source

Right Ventricular and Left Atrial Strain Predict Volumetric Response to Cardiac Resynchronization Therapy. [PDF]

J Cardiovasc Dev Dis
Ching S, Li JJ, Werhahn SM, Beyer RE, Estepa M, Stehning C, Hashemi D, Solowjowa N, Klein C, Dreger H, Kelle S, Doeblin P.   +11 more
europepmc   +1 more source

Real‐world outcomes in cardiac resynchronization therapy patients: Primary results of the SMART registry

ESC Heart Failure, Volume 12, Issue 3, Page 1832-1847, June 2025.
Abstract Aims Cardiac resynchronization therapy (CRT) is guideline recommended for the treatment of symptomatic heart failure (HF) with reduced left ventricular ejection fraction and prolonged QRS. However, patients with common comorbidities, such as persistent/permanent atrial fibrillation (AF), are often under‐represented in clinical trials.
Ignacio García‐Bolao, Roy S. Gardner, Daniel Gras, Antonio D'Onofrio, George Mark, Devi Nair, Nicolas Lellouche, Miroslav Novak, Ronald Lo, Engwooi Chew, David Wright, Andrew Kaplan, Matteo Bertini, Sara Veraghtert, Michelle M. Harbin, Elizabeth Matznick, Patrick Yong, Kenneth M. Stein   +17 more
wiley   +1 more source

Usefulness of Cardiac Resynchronization Therapy Optimization Using Combined Electrocardiography and Echocardiography. [PDF]

Cureus
Tachibana M, Hayashida A, Take Y, Banba K, Kimura A, Shigematsu T, Hirohata A.   +6 more
europepmc   +1 more source

Design and rationale of the eLym™ System for Decompensation of Excess Lymphatic Fluid via the Thoracic Duct in Acute Heart Failure (DELTA‐HF)

ESC Heart Failure, Volume 12, Issue 3, Page 1719-1726, June 2025.
Abstract Aims The interstitial space is the major compartment in which the excess fluid is located, forming peripheral congestion in acute decompensated heart failure (ADHF). The lymphatic system is responsible for the constant drainage of the compartment.
Jan Biegus, JoAnn Lindenfeld, G. Michael Felker, George Bakris, Michael Jonas, Anuradha Lala, Zviad Kereselidze, George Khabeishvili, Irakli Gogorishvili, Julio Núñez, Antoni Bayés‐Genís, Piotr Ponikowski, William T. Abraham   +12 more
wiley   +1 more source

Reply to the use of tissue characterization using cardiac magnetic resonance imaging and response to cardiac resynchronization therapy. [PDF]

Europace
Liew A, Howell S, Rinaldi CA.
europepmc   +1 more source

Guideline‐directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort

ESC Heart Failure, Volume 12, Issue 3, Page 1861-1871, June 2025.
Abstract Aims Guideline‐directed medical therapy (GDMT) is recommended for all patients with heart failure with reduced ejection fraction (HFrEF). Despite this, little data exist describing GDMT use in diverse, real‐world populations including the use of vasodilators, prescribed primarily to Black populations.
Natalia C. Berry, Yi‐Shin Sheu, Karen Chesbrough, R. Clayton Bishop, Suma Vupputuri   +4 more
wiley   +1 more source

Application and Research of Left Bundle Branch-Optimized Cardiac Resynchronization Therapy in Ischemic Cardiomyopathy. [PDF]

Rev Cardiovasc Med
Zhang D, Lang M, Prakash Earnest BS, Ali Abdou IEM.   +3 more
europepmc   +1 more source